115 related articles for article (PubMed ID: 36814285)
21. Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms.
Baranwal A; Hahn CN; Shah MV; Hiwase DK
Curr Hematol Malig Rep; 2022 Dec; 17(6):254-265. PubMed ID: 35986863
[TBL] [Abstract][Full Text] [Related]
22. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
Yun J; Song H; Kim SM; Kim S; Kwon SR; Lee YE; Jeong D; Park JH; Kwon S; Yun H; Lee DS
Hum Genomics; 2023 Feb; 17(1):13. PubMed ID: 36814285
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Andrés-Zayas C; Suárez-González J; Rodríguez-Macías G; Dorado N; Osorio S; Font P; Carbonell D; Chicano M; Muñiz P; Bastos M; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
Mol Oncol; 2021 Sep; 15(9):2273-2284. PubMed ID: 33533142
[TBL] [Abstract][Full Text] [Related]
24. The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.
Li P; Brown S; Williams M; White T; Xie W; Cui W; Peker D; Lei L; Kunder CA; Wang HY; Murray SS; Vagher J; Kovacsovics T; Patel JL
Blood; 2022 Aug; 140(7):716-755. PubMed ID: 35671390
[TBL] [Abstract][Full Text] [Related]
25. Clinical and molecular correlates of somatic and germline
Badar T; Nanaa A; Foran JM; Viswanatha D; Al-Kali A; Lasho T; Finke C; Alkhateeb HB; He R; Gangat N; Shah M; Tefferi A; Mangaonkar AA; Litzow MR; Ongie LJ; Chlon T; Ferrer A; Patnaik MM
Haematologica; 2023 Nov; 108(11):3033-3043. PubMed ID: 37199125
[TBL] [Abstract][Full Text] [Related]
26. Therapy-related myeloid neoplasms in 39 Korean patients: a single institution experience.
Huh HJ; Lee SH; Yoo KH; Sung KW; Koo HH; Kim K; Jang JH; Jung C; Kim SH; Kim HJ
Ann Lab Med; 2013 Mar; 33(2):97-104. PubMed ID: 23483787
[TBL] [Abstract][Full Text] [Related]
27. Next generation sequencing in therapy-related myeloid neoplasms compared to
Claerhout H; Vranckx H; Lierman E; Michaux L; Boeckx N
Acta Clin Belg; 2022 Jun; 77(3):658-663. PubMed ID: 34197279
[TBL] [Abstract][Full Text] [Related]
28. Primer on Hereditary Cancer Predisposition Genes Included Within Somatic Next-Generation Sequencing Panels.
Akras Z; Bungo B; Leach BH; Marquard J; Ahluwalia M; Carraway H; Grivas P; Sohal DPS; Funchain P
JCO Precis Oncol; 2019 Dec; 3():1-11. PubMed ID: 35100683
[TBL] [Abstract][Full Text] [Related]
29. R-loop proximity proteomics identifies a role of DDX41 in transcription-associated genomic instability.
Mosler T; Conte F; Longo GMC; Mikicic I; Kreim N; Möckel MM; Petrosino G; Flach J; Barau J; Luke B; Roukos V; Beli P
Nat Commun; 2021 Dec; 12(1):7314. PubMed ID: 34916496
[TBL] [Abstract][Full Text] [Related]
30. Ddx41 inhibition of DNA damage signaling permits erythroid progenitor expansion in zebrafish.
Weinreb JT; Gupta V; Sharvit E; Weil R; Bowman TV
Haematologica; 2022 Mar; 107(3):644-654. PubMed ID: 33763998
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia.
Kim B; Yun W; Lee ST; Choi JR; Yoo KH; Koo HH; Jung CW; Kim SH
Sci Rep; 2020 Aug; 10(1):14297. PubMed ID: 32868804
[TBL] [Abstract][Full Text] [Related]
32. The Human Gene Mutation Database (HGMD
Stenson PD; Mort M; Ball EV; Chapman M; Evans K; Azevedo L; Hayden M; Heywood S; Millar DS; Phillips AD; Cooper DN
Hum Genet; 2020 Oct; 139(10):1197-1207. PubMed ID: 32596782
[TBL] [Abstract][Full Text] [Related]
33. Role of RUNX Family Transcription Factors in DNA Damage Response.
Samarakkody AS; Shin NY; Cantor AB
Mol Cells; 2020 Feb; 43(2):99-106. PubMed ID: 32024352
[TBL] [Abstract][Full Text] [Related]
34. Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up.
Baliakas P; Tesi B; Wartiovaara-Kautto U; Stray-Pedersen A; Friis LS; Dybedal I; Hovland R; Jahnukainen K; Raaschou-Jensen K; Ljungman P; Rustad CF; Lautrup CK; Kilpivaara O; Kittang AO; Grønbæk K; Cammenga J; Hellström-Lindberg E; Andersen MK
Hemasphere; 2019 Dec; 3(6):e321. PubMed ID: 31976490
[TBL] [Abstract][Full Text] [Related]
35. FANCM suppresses DNA replication stress at ALT telomeres by disrupting TERRA R-loops.
Pan X; Chen Y; Biju B; Ahmed N; Kong J; Goldenberg M; Huang J; Mohan N; Klosek S; Parsa K; Guh CY; Lu R; Pickett HA; Chu HP; Zhang D
Sci Rep; 2019 Dec; 9(1):19110. PubMed ID: 31836759
[TBL] [Abstract][Full Text] [Related]
36. DNA repair functional analyses of NBN hypomorphic variants associated with NBN-related infertility.
Fiévet A; Bellanger D; Zahed L; Burglen L; Derrien AC; Dubois d'Enghien C; Lespinasse J; Parfait B; Pedespan JM; Rieunier G; Stoppa-Lyonnet D; Stern MH
Hum Mutat; 2020 Mar; 41(3):608-618. PubMed ID: 31729086
[TBL] [Abstract][Full Text] [Related]
37. The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution.
Singhal D; Wee LYA; Kutyna MM; Chhetri R; Geoghegan J; Schreiber AW; Feng J; Wang PP; Babic M; Parker WT; Hiwase S; Edwards S; Moore S; Branford S; Kuzmanovic T; Singhal N; Gowda R; Brown AL; Arts P; To LB; Bardy PG; Lewis ID; D'Andrea RJ; Maciejewski JP; Scott HS; Hahn CN; Hiwase DK
Leukemia; 2019 Dec; 33(12):2842-2853. PubMed ID: 31089247
[TBL] [Abstract][Full Text] [Related]
38. Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms.
Kim B; Lee H; Jang J; Kim SJ; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR
PLoS One; 2019; 14(3):e0212228. PubMed ID: 30840646
[TBL] [Abstract][Full Text] [Related]
39. Predicting Splicing from Primary Sequence with Deep Learning.
Jaganathan K; Kyriazopoulou Panagiotopoulou S; McRae JF; Darbandi SF; Knowles D; Li YI; Kosmicki JA; Arbelaez J; Cui W; Schwartz GB; Chow ED; Kanterakis E; Gao H; Kia A; Batzoglou S; Sanders SJ; Farh KK
Cell; 2019 Jan; 176(3):535-548.e24. PubMed ID: 30661751
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
